Maria Florencia Clarens

Maria Florencia Clarens

Auto-generated profile, based on publicly available information

Maria Florencia Clarens

Department of Cognitive Neurology Fleni, Ciudad Autónoma de Buenos Aires Buenos Aires Argentina

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Neuropsychology
Verified
Journal Article
Closed access
FQFrançois Quesque
François Quesque
ACAntoine Coutrot
Antoine Coutrot
SCSharon Cox
Sharon Cox
LSLeonardo Cruz de Souza
Leonardo Cruz de Souza
SBSandra Baez
Sandra Baez
MBMaxime Bertoux
Maxime Bertoux
Measures of social cognition have now become central in neuropsychology, being essential for early and differential diagnoses, follow-up, and rehabilitation in a wide range of conditions. With the scientific world becoming increasingly interconnected, international neuropsychological and medical collaborations are burgeoning to tackle the global challenges that are mental health conditions. These initiatives commonly merge data across a diversity of populations and countries, while ignoring their specificity. In this context, we aimed to estimate the influence of participants' nationality on social cognition evaluation. This issue is of particular importance as most cognitive tasks are developed in highly specific contexts, not representative of that encountered by the world's population. Through a large international study across 18 sites, neuropsychologists assessed core aspects of social cognition in 587 participants from 12 countries using traditional and widely used tasks. Age, gender, and education were found to impact measures of mentalizing and emotion recognition. After controlling for these factors, differences between countries accounted for more than 20% of the variance on both measures. Importantly, it was possible to isolate participants' nationality from potential translation issues, which classically constitute a major limitation. Overall, these findings highlight the need for important methodological shifts to better represent social cognition in both fundamental research and clinical practice, especially within emerging international networks and consortia. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

1 April 2018 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
PMPatricio Chrem Méndez
Patricio Chrem Méndez
ICIsmael Calandri
Ismael Calandri
FNFederico Nahas
Federico Nahas
Maria Julieta RussoMaria Julieta Russo
Maria Julieta Russo
IDIgnacio Demey
Ignacio Demey
GSGustavo Sevlever
Gustavo Sevlever
The Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI) study is a longitudinal prospective cohort of 50 participants at a single institution in Buenos Aires, Argentina. Longitudinal assessments on a neuropsychological test battery were performed on 15 controls, 24 mild cognitive impairment (MCI) patients and 12 Alzheimer's disease (AD) dementia patients. In our study population, there was a high prevalence of positive AD biomarkers in the AD group, 92.3% (12/13); and a low prevalence in the normal controls, 20%; almost half (48%) of the patients diagnosed with MCI had positive amyloid detection. After a one year, the significant differences found at baseline on neuropsychological testing were similar at the follow-up assessment even though the AD group had significantly altered its functional performance (FAQ and CDR). The exception was semantic fluency, which showed greater impairment between the AD group and MCI and normal controls respectively. For these tests, the addition of AD biomarkers as a variable did not significantly alter the variations previously found for the established clinical group's model. Finally, the one-year conversion rate to dementia was 20% in the MCI cohort.

6 December 2025 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
ADAlessandra Dodich
Alessandra Dodich
APAndrea Panzavolta
Andrea Panzavolta
GFGiulia Funghi
Giulia Funghi
CMClaudia Meli
Claudia Meli
CFCristina Festari
Cristina Festari
ABAngela Bradshaw
Angela Bradshaw
Socio-cognitive assessment in neurocognitive disorders (NCDs) is rare in clinical practice and no consensus exists as to a uniform operationalization of so

17 December 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
FMFlorentina Morello‐Garcia
Florentina Morello‐Garcia
NCNicolas Corvalan
Nicolas Corvalan
JLJorge Llibre‐Guerra
Jorge Llibre‐Guerra
MAMicaela Arruabarrena
Micaela Arruabarrena
MCMaría Florencia Clarens
María Florencia Clarens
LCLucia Crivelli
Lucia Crivelli
Early‐career researchers from low‐ and middle‐income countries face systemic barriers to professional development and leadership growth. This article presents results from an initiative led by the World Young Leaders in Dementia (WYLD), including a leadership‐focused session at the Alzheimer's Association International Conference 2024 and a global survey completed by 130 dementia researchers from 17 countries. The survey explored five capacity‐building domains critical for leadership development. Over half of the survey respondents stated that scientific research in their country was not prioritized in public policy. Additionally, only 39% report holding full‐time academic positions. The most cited challenges included lack of funding sources, training opportunities, and physical workspace. These findings highlight the urgent need to invest in research, training, and infrastructure to support future scientific leaders. As dementia incidence rises, prioritizing capacity building is essential to ensure global equity in research. Highlights: Early‐career dementia researchers face major barriers, especially in LMICs. A networking session and a global survey explored capacity‐building needs in dementia research. Key obstacles: lack of funding, training, workspace, and protected research time. Leadership development is a critical component of sustainable research capacity.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MCMaria Florencia Clarens
Maria Florencia Clarens
PMPatricio Chrem Mendez
Patricio Chrem Mendez
FTFernanda Tapajoz
Fernanda Tapajoz
CMCarlos Martinez
Carlos Martinez
BHBelén Helou
Belén Helou
RARicardo Francisco Allegri
Ricardo Francisco Allegri
Background: In recent years, there has been an increase in the number of case reports of families with autosomal dominant Alzheimer’s disease (ADAD) in Latin America (LA). Nevertheless, little is known about the clinical phenotypes and demographic characteristics of mutations in each country. Past literature has proved that variants in LA have different and unique characteristics than those reported in Asia, North America, and Europe. Clinical heterogeneity in ADAD supports the need to study clinical phenotypes, especially in preclinical stages, to develop cognitive and clinical markers of the disease.We aimed to describe clinical and cognitive characteristics at baseline assessment of an Argentina PSEN1 p.M146L family enrolled at DIAN.Method: Fifteen Dian Participants living in Buenos Aires and its suburbs and in Taco Pozo, a rural and isolated community from the Province of Salta, positive for the PSEN1 p.M146L mutation, were recruited. DNA was obtained from peripheral blood leukocytes according to standard protocols. In addition, exon 5 of the PSEN1 gene was PCR‐amplified, and Sanger sequencing was performed. NACC Uniform Data Set clinical assessment, including the 2.0 UDS Neuropsychological Battery, was administered. Two groups were used to compare cognitive data: Patients with CDR:0 (n:10) and patients with CDR>0 (n:5).Result: The mean age at symptom onset reported in this cohort was 42,90 (SD: 4,62). Significant differences were found in several cognitive measures: Logical Memory Immediate, TMT B and Digit Backward (<0,001); MMSE, Category Fluency Animals, TMT A and Digit Symbol(<0,05). In neurological signs, paraplegia was reported in one of the patients.Conclusion: As expected, differences in neuropsychological tests showed a prevalence of memory deficits, however, dysexecutive symptoms were also present for this mutation. Paraplegia in PSEN1 p.M146L has not been reported in the literature so far. Ongoing longitudinal work will be important in tracking changes in this cohort. Other characteristics, proper of underrepresented groups, such as socioeconomic status, education, race, and ethnicity, deserve appropriate follow‐up. Future studies are planned, comparing urban and rural populations in this cohort with the same mutation.